We performed a pilot study on a dendritic cell (DC)-based vaccine in 4 pati
ents with advanced renal cell carcinoma. The vaccine consisted of cultured
blood DCs loaded with autologous tumor cell lysate plus keyhole limpet hemo
cyanin (KLH) and matured with a combination of tumor necrosis factor alpha
and prostaglandin E-2 We describe the immune response against KLH induced b
y DC-based immunization in a patient undergoing an objective partial respon
se and compare it with the responses observed in patients with either stabl
e or progressive disease. The patient with the clinical response developed
strong delayed-type hypersensitivity (DTH) against KLH after a single vacci
nation with antigen-loaded DCs, whereas the other patients failed to develo
p DTH reactivity even after repeated vaccinations. Antigenic stimulation of
mononuclear cells (MNCs) induced proliferation and IFN-gamma but not IL-4
production as well as expression of the chemokine receptor CXCR3 consistent
with a T-helper (Th) type-1 bias. Exogenous IL-12 enhanced and exogenous I
L-4 diminished IFN-gamma production. In the 2 patients with stable disease
two or more vaccinations were required to induce maximal MNC responses. In
the patient with progressive disease MNC responses were hardly detectable.
Anti-KLH antibodies appeared with different kinetics but could be detected
in the serum of all patients. Isotype analysis revealed the presence of IgM
, IgG(1), IgG(2) and IgG(3) as well as IgA and complete absence of IgE. The
patient with progressive disease also developed IgG(4) antibodies indicati
ve of a deviation towards Th2. Cultured blood DCs can be a potent vaccine f
or the antigen-specific immunization of patients with advanced kidney cance
r. KLH serves as a tracer molecule which allows determination of the magnit
ude, kinetics and Th bias of the cellular and humoral immune response induc
ed by DC-based immunization. The data also suggest that Th type-1-dominant
immune responses involving DTH reaction are required for the induction of t
umor regression. Copyright (C) 2000 S. Karger AG, Basel.